Cargando…

Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma

BACKGROUND: The immune status within the tumor microenvironment has not been well determined in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the distributions of tumor-infiltrating T lymphocytes (TILs), and analyze their associations with clinical characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kaiyan, Zhu, Ziyu, Zhang, Nan, Cheng, Guoping, Zhang, Fanrong, Jin, Jiaoyue, Wu, Junzhou, Ying, Lisha, Mao, Weimin, Su, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687116/
https://www.ncbi.nlm.nih.gov/pubmed/28949934
http://dx.doi.org/10.12659/MSM.904154
_version_ 1783278907639726080
author Chen, Kaiyan
Zhu, Ziyu
Zhang, Nan
Cheng, Guoping
Zhang, Fanrong
Jin, Jiaoyue
Wu, Junzhou
Ying, Lisha
Mao, Weimin
Su, Dan
author_facet Chen, Kaiyan
Zhu, Ziyu
Zhang, Nan
Cheng, Guoping
Zhang, Fanrong
Jin, Jiaoyue
Wu, Junzhou
Ying, Lisha
Mao, Weimin
Su, Dan
author_sort Chen, Kaiyan
collection PubMed
description BACKGROUND: The immune status within the tumor microenvironment has not been well determined in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the distributions of tumor-infiltrating T lymphocytes (TILs), and analyze their associations with clinical characteristics and prognosis; as well as investigate the expression of programmed death-ligand 1 (PD-L1) which has been identified as a favorable indicator of prognosis in our previous study on ESCC. MATERIAL/METHODS: Five hundred and thirty-six patients who underwent radical surgery for ESCC between January 2008 and April 2012 in Department of Thoracic Surgery at Zhejiang Cancer Hospital were included in the study. Immunohistochemistry was used to investigate the infiltration of various TILs (CD3+, CD4+, CD8+ T lymphocytes) in ESCC tissues. Chi-square test and Cox proportional hazards regression were used to explore the correlations between TILs abundance and clinicopathological variables and survival. RESULTS: The infiltration of intraepithelial CD4+ (iCD4+) lymphocytes was markedly higher than it in the stromal region (44.2% for intraepithelial versus 28.9% for stromal, p<0.001). Moreover, increased iCD4+ lymphocytes were significantly associated with longer overall survival (OS, p=0.001) in univariate analysis and were identified as an independent predictor for improved OS in multivariate analysis (hazard ratio [HR]=0.67, 95% confidence interval [CI]: 0.51–0.88, p=0.040). Neither the infiltration of CD3+ nor CD8+ lymphocytes showed the prognostic value in ESCC (p>0.05). Unexpectedly, combined with our previous study results, the TILs infiltration in ESCC showed an inverse association with the expression of PD-L1 (p=0.027). CONCLUSIONS: Our results suggested that iCD4+ lymphocytes infiltration could be a favorable indicator for prognosis in ESCC.
format Online
Article
Text
id pubmed-5687116
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-56871162017-11-17 Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma Chen, Kaiyan Zhu, Ziyu Zhang, Nan Cheng, Guoping Zhang, Fanrong Jin, Jiaoyue Wu, Junzhou Ying, Lisha Mao, Weimin Su, Dan Med Sci Monit Clinical Research BACKGROUND: The immune status within the tumor microenvironment has not been well determined in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the distributions of tumor-infiltrating T lymphocytes (TILs), and analyze their associations with clinical characteristics and prognosis; as well as investigate the expression of programmed death-ligand 1 (PD-L1) which has been identified as a favorable indicator of prognosis in our previous study on ESCC. MATERIAL/METHODS: Five hundred and thirty-six patients who underwent radical surgery for ESCC between January 2008 and April 2012 in Department of Thoracic Surgery at Zhejiang Cancer Hospital were included in the study. Immunohistochemistry was used to investigate the infiltration of various TILs (CD3+, CD4+, CD8+ T lymphocytes) in ESCC tissues. Chi-square test and Cox proportional hazards regression were used to explore the correlations between TILs abundance and clinicopathological variables and survival. RESULTS: The infiltration of intraepithelial CD4+ (iCD4+) lymphocytes was markedly higher than it in the stromal region (44.2% for intraepithelial versus 28.9% for stromal, p<0.001). Moreover, increased iCD4+ lymphocytes were significantly associated with longer overall survival (OS, p=0.001) in univariate analysis and were identified as an independent predictor for improved OS in multivariate analysis (hazard ratio [HR]=0.67, 95% confidence interval [CI]: 0.51–0.88, p=0.040). Neither the infiltration of CD3+ nor CD8+ lymphocytes showed the prognostic value in ESCC (p>0.05). Unexpectedly, combined with our previous study results, the TILs infiltration in ESCC showed an inverse association with the expression of PD-L1 (p=0.027). CONCLUSIONS: Our results suggested that iCD4+ lymphocytes infiltration could be a favorable indicator for prognosis in ESCC. International Scientific Literature, Inc. 2017-09-26 /pmc/articles/PMC5687116/ /pubmed/28949934 http://dx.doi.org/10.12659/MSM.904154 Text en © Med Sci Monit, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Chen, Kaiyan
Zhu, Ziyu
Zhang, Nan
Cheng, Guoping
Zhang, Fanrong
Jin, Jiaoyue
Wu, Junzhou
Ying, Lisha
Mao, Weimin
Su, Dan
Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title_full Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title_fullStr Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title_full_unstemmed Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title_short Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
title_sort tumor-infiltrating cd4+ lymphocytes predict a favorable survival in patients with operable esophageal squamous cell carcinoma
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687116/
https://www.ncbi.nlm.nih.gov/pubmed/28949934
http://dx.doi.org/10.12659/MSM.904154
work_keys_str_mv AT chenkaiyan tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT zhuziyu tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT zhangnan tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT chengguoping tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT zhangfanrong tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT jinjiaoyue tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT wujunzhou tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT yinglisha tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT maoweimin tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma
AT sudan tumorinfiltratingcd4lymphocytespredictafavorablesurvivalinpatientswithoperableesophagealsquamouscellcarcinoma